These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 23435033
1. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future. Clarkson TB, Meléndez GC, Appt SE. Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033 [Abstract] [Full Text] [Related]
2. Is the estrogen controversy over? Deconstructing the Women's Health Initiative study: a critical evaluation of the evidence. Harman SM, Naftolin F, Brinton EA, Judelson DR. Ann N Y Acad Sci; 2005 Jun; 1052():43-56. PubMed ID: 16024750 [Abstract] [Full Text] [Related]
3. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis. Banks E, Canfell K. Am J Epidemiol; 2009 Jul 01; 170(1):24-8. PubMed ID: 19468078 [Abstract] [Full Text] [Related]
4. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD. Ann N Y Acad Sci; 2005 Jun 01; 1052():57-74. PubMed ID: 16024751 [Abstract] [Full Text] [Related]
5. Postmenopausal hormone therapy: new questions and the case for new clinical trials. Manson JE, Bassuk SS, Harman SM, Brinton EA, Cedars MI, Lobo R, Merriam GR, Miller VM, Naftolin F, Santoro N. Menopause; 2006 Jun 01; 13(1):139-47. PubMed ID: 16607110 [Abstract] [Full Text] [Related]
6. Postmenopausal hormones and coronary artery disease: potential benefits and risks. Lobo RA. Climacteric; 2007 Oct 01; 10 Suppl 2():21-6. PubMed ID: 17882668 [Abstract] [Full Text] [Related]
7. Controversies about HRT--lessons from monkey models. Clarkson TB, Appt SE. Maturitas; 2005 May 16; 51(1):64-74. PubMed ID: 15883111 [Abstract] [Full Text] [Related]
9. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause. Langer RD. Climacteric; 2010 Aug 16; 13(4):303-6. PubMed ID: 20540591 [Abstract] [Full Text] [Related]
10. Recent reversal of trends in hormone therapy use in a European population. Morabia A, Costanza MC. Menopause; 2006 Aug 16; 13(1):111-5. PubMed ID: 16607106 [Abstract] [Full Text] [Related]
11. Menopause and stroke and the effects of hormonal therapy. Lobo RA. Climacteric; 2007 Oct 16; 10 Suppl 2():27-31. PubMed ID: 17882669 [Abstract] [Full Text] [Related]
14. A comparative review of the risks and benefits of hormone replacement therapy regimens. Warren MP. Am J Obstet Gynecol; 2004 Apr 16; 190(4):1141-67. PubMed ID: 15118656 [Abstract] [Full Text] [Related]
15. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence? Salpeter S. Climacteric; 2005 Dec 16; 8(4):307-10. PubMed ID: 16390764 [Abstract] [Full Text] [Related]
17. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis. Hodis HN, Mack WJ, Shoupe D, Azen SP, Stanczyk FZ, Hwang-Levine J, Budoff MJ, Henderson VW. Menopause; 2015 Apr 16; 22(4):391-401. PubMed ID: 25380275 [Abstract] [Full Text] [Related]
18. Recent epidemiological evidence relevant to the clinical management of the menopause. Shapiro S. Climacteric; 2007 Oct 16; 10 Suppl 2():2-15. PubMed ID: 17882666 [Abstract] [Full Text] [Related]
19. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment. Gungor F, Kalelioglu I, Turfanda A. Angiology; 2009 Oct 16; 60(3):308-17. PubMed ID: 18505742 [Abstract] [Full Text] [Related]
20. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003. Burger H. Climacteric; 2003 May 16; 6 Suppl 1():11-36. PubMed ID: 12945798 [Abstract] [Full Text] [Related] Page: [Next] [New Search]